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Abstract
We examined whether variants in genes related to sex hormone biosynthesis and metabolism were 
associated with hypospadias in humans. We examined 332 relatively common tagSNPs in 20 
genes. Analyses included 633 cases (84 mild, 322 moderate, 212 severe, 15 undetermined 
severity) and 855 population-based non-malformed male controls born in California from 1990–
2003. We used logistic regression models to estimate odds ratios (OR) and 95 percent confidence 
intervals (CI) for each SNP. Several of the 332 studied SNPs had p<0.01: one in CYP3A4, four in 
HSD17B3, one in HSD3B1, 2 in STARD3 10 in SRD5A2 and seven in STS. In addition, haplotype 
analyses gave several associations with p<0.01. For HSD17B3, 14-SNP and 5-SNP blocks had 
ORs of 1.5 (95% CI 1.1, 2.0, p<0.001) and 2.8 (95% CI 1.6, 4.8, p<0.001), respectively. For 
SRD5A2, 9-SNP, 3-SNP and 8-SNP blocks had ORs of 1.7 (95% CI 1.3, 2.2, p<0.001), 1.4 (95% 
CI 1.1, 1.8, p=0.008) and 1.5 (95% CI 1.2, 1.9, p=0.002), respectively. Our study indicates that 
several genes that contribute to sex hormone biosynthesis and metabolism are associated with 
hypospadias risk.
INTRODUCTION
Hypospadias is a common congenital malformation in which the urethral meatus is on the 
ventral side of the penis. Familial patterns suggest that genetic factors substantially 
contribute to its etiology (Schnack and others, 2008). Normal urethral closure, which occurs 
during the 8th–14th weeks of gestation, involves a continuous process of ventral fusion in the 
proximal to distal direction (Kurzrock and others, 1999; Seifert and others, 2008; Van Der 
Werff and others, 2000). This process requires fetal synthesis of testosterone, conversion to 
dihydrotestosterone (DHT), DHT binding to the androgen receptor (AR), and appropriate 
AR signaling. Estrogens, as well as progesterone, may interfere with this process in the fetus 
(Kim and others, 2004; Manson and Carr, 2003; Wright and others, 1983). We therefore 
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hypothesized that variability in genes that contribute to fetal sex hormone biosynthesis and 
metabolism is associated with hypospadias risk. In particular, we hypothesize that lower 
testosterone or DHT levels or higher estrogen or progesterone levels would be associated 
with increased risk.
Many genes contribute to these pathways, and several have been examined by previous 
studies of hypospadias. SRD5A2 is critical to conversion of testosterone to DHT in the 
urethral seam, and its variants have been associated with hypospadias in several small 
studies (Makridakis and others, 2000; Samtani and others, 2011; Sata and others, 2010; Thai 
and others, 2005) but not in one larger study (van der Zanden and others, 2010). Small 
studies have also suggested that variants in CYP17A1 (Qin and others, 2012; Samtani and 
others, 2010), HSD3B2 (Codner and others, 2004), HSD17B3 (Sata and others, 2010), and 
CYP1A1 (Kurahashi and others, 2005) are associated with hypospadias.
We examined whether variants in 20 genes that contribute to sex hormone synthesis and 
metabolism were associated with hypospadias (Table 1). Specifically, we examined over 
300 relatively common variants in a large population of California male infants. Several of 
the genes have been examined previously for an association with hypospadias (as noted 
above) but most have not.
METHODS
The study population included all male infants born from 1990–2003 to mothers who were 
residents of eight California Central Valley counties (Fresno, Kern, Kings, Madera, Merced, 
San Joaquin, Stanislaus, and Tulare counties) and from 1990–1997 (7/1/1990–12/31/1997) 
to mothers who were residents of Los Angeles, San Francisco, and Santa Clara counties, 
reflecting counties where case ascertainment was actively being conducted by the California 
Birth Defects Monitoring Program (CBDMP). CBDMP staff ascertained cases by reviewing 
medical records at hospitals and genetic centers in the relevant California counties (Croen 
and others, 1991).
Cases were classified by severity, which was based on the reported anatomical position of 
the urethral opening. Mild cases were those for which the meatus was limited to the coronal 
or glanular penis (British Pediatric Association [BPA] codes 752.605, 752.625), moderate 
cases were those for which the meatus was on the penile shaft, and severe cases were those 
for which the meatus was at the peno-scrotal junction or perineal area (BPA codes 752.606, 
752.607, 752.626, 752.627). Assignment of severity was finalized based on review by a 
medical geneticist (EJL or Dr. Cynthia Curry) (Carmichael and others, 2003). Cases for 
which the anatomical position was described as “not otherwise specified” (BPA codes 
752.600, 752.620) were excluded. Cases having a known single gene disorder or 
chromosomal abnormality were excluded.
The underlying study population included 1,246,172 non-malformed live born male infants 
eligible for control selection. We randomly selected 931 controls with available newborn 
bloodspots for study, in proportion to the underlying birth population for that year, to give 
an approximate 2:1 ratio of controls to cases from Central Valley counties and a 1:1 ratio 
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from non-Central Valley counties. The ratio differed due to the presence of a secondary on-
going study in the Central Valley that allowed for a larger control group. No control infant 
had a structural birth defect.
For cases and controls, information on the following descriptive covariates was derived from 
birth certificates: maternal race-ethnicity, education, age, and parity; plurality; and infant 
birthweight and gestational age at delivery. Cases and controls were linked with archived 
newborn bloodspots, which served as the source of DNA for genotyping. In total, 667 (88% 
of eligible) cases and 931 (93% of eligible) controls were available for genotyping.
Genomic DNA was extracted from bloodspots using MasterPure™ Complete DNA and 
RNA Purification Kit (Epicentre Biotechnologies Madison, WI) and 10 ng genomic DNA 
was then used for whole genome amplification (Qiagen Repli-g® kit). TagSNPs that assay 
known common SNPs either directly or indirectly via linkage disequilibrium among 
measured and unmeasured SNPs were selected using the Genome Variation Server (http://
gvs.gs.washington.edu/GVS/). The program provided tagSNPs that cover common variation 
at r2>0.80 across each candidate gene for a “cosmopolitan” population, including Hispanics. 
TagSNPs with minor allele frequencies (MAF) >10% were selected. SNPs were genotyped 
using a custom multiplex Illumina GoldenGate assay.
We started with 380 SNPs from the candidate genes in the GoldenGate assay. We excluded 
29 SNPs for which the data indicated poor clustering of results and 2 SNPs with a call rate 
<90%. We also excluded 106 subjects (32 cases, 74 controls) with sample call rates <90%, 
leaving 635 cases (84 mild, 323 moderate, 213 severe, 15 unknown) and 857 controls for 
analyses. We then undertook a Hardy-Weinberg equilibrium test for each SNP among 
controls, which resulted in excluding 17 additional SNPs (p-value <0.005 among non-
Hispanic whites or Hispanics), leaving 332 SNPs for analysis. All 3 SNPs for CYP21A2 
were excluded. The genes and number of SNPs per gene are described in Table 1.
We genotyped 106 ancestry informative marker (AIM) SNPs that were selected to 
discriminate Native American, African, and European ancestry (Choudhry and others, 2010; 
Gamboa-Melendez and others, 2012; Risch and others, 2009; Via and others, 2010). Four of 
the 106 AIMs were excluded because they had a call rate lower than 90%. To estimate 
individual ancestry estimates among cases and controls, we used the program Structure 2.1 
(Falush and others, 2003; Pritchard and others, 2000). Structure was run using the admixture 
model with unlinked markers, with 50,000 burn-in iterations and 50,000 further iterations. 
We assumed three ancestral populations. Structure provided variables reflecting the 
proportions of Native American, African and European ancestry for each case or control. 
Given that the three proportions sum to one, we only incorporated two (Native American 
and African) into our analyses to adjust for potential population stratification.
We used logistic regression to examine the association of each candidate gene SNP with risk 
of hypospadias, comparing the homozygous and heterozygous variant genotypes with the 
homozygous wildtype genotype (the more frequent allele among all controls was designated 
as wildtype). We considered results to be significant if they had p<0.01. We considered the 
possibility for heterogeneity of results across ethnic groups by comparing risks among self-
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identified non-Hispanic white and Hispanic subjects by examining models restricted to these 
two groups that contained product terms to estimate interaction (interaction was not assessed 
for “other” race-ethnicity, because it was a smaller group and heterogeneous). For SNPs for 
which the overall p-value for the product term was less than 0.10 (n=12), we focused on 
stratified results. We conducted analyses of all cases grouped together as well as separate 
analyses by severity of phenotype (mild, moderate, severe).
For the fifteen genes for which there were more than 5 SNPs (COMT, CYP11A1, CYP17A1, 
CYP19A1, CYP3A4, HSD17B2, HSD17B3, HSD3B1, HSD3B2, SRD5A1, SRD5A2, 
STARD3, STS, SULT1E1, SULT2A1), we examined haplotypes. We used Haploview 4.2 to 
determine the LD structure in the region and to define the haplotype blocks and their 
frequencies based on all subjects’ genotypes (Barrett and others, 2005). The most common 
haplotype was the reference. Maximum likelihood estimates of odds ratios and their 
corresponding 95% confidence intervals (CI) were calculated from logistic regression 
models to estimate relative risks.
We also evaluated genetic risk scores created by combining high-risk SNPs. For each 
individual we counted the number of genes in which they carried an associated variant 
(based on p<0.01 as our criterion). For variants with ORs<1, the reference genotype 
(homozygous wildtype) was scored as the risk genotype. We calculated scores overall and 
separately by severity (applying the p-value criterion within each group, such that a different 
set of variants was scored within each group).
All odds ratios were adjusted for the two ancestral proportion variables and for maternal 
residence in the Central Valley (yes/no) due to the differing case-control ratio based on this 
variable that was inherent to the study design. In addition, non-stratified results were 
adjusted for maternal race-ethnicity (Hispanic, non-Hispanic white, or other). Two cases and 
two controls had missing race-ethnicity, such that SNP-based analyses included 855 controls 
and a maximum 633 cases (84 mild, 322 moderate, 212 severe, 15 uncertain after clinician 
review, which were included only in the analyses of all cases together).
RESULTS
Case mothers were more likely than control mothers to be non-Hispanic white, more highly 
educated, older, and nulliparous (Table 2). Cases were more likely to be low birthweight and 
delivered before 37 weeks of gestation.
Several SNPs had p<0.01 for at least one comparison (Table 3). One CYP3A4 SNP was 
associated with increased risk, specifically for moderate hypospadias. For four HSD17B3 
SNPs, the heterozygous phenotypes were associated with risk, for moderate and severe 
hypospadias. For three of these SNPs, the odds ratios were even higher for the homozygous 
genotype (2- to 3-fold increased risk), but confidence intervals included one, likely due to 
smaller sample sizes for these comparisons. One HSD3B1 SNP and two STARD3 SNPs were 
associated with risk; results varied between whites and Hispanics and by severity. Ten 
SRD5A2 SNPs were associated. As with HSD17B3, odds ratios were particularly high 
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among moderate and severe cases, and for the homozygous genotypes. Seven STS SNPs 
were associated with risk; results tended to be elevated regardless of severity.
High linkage disequilibrium was present among some of the SNPs reported in Table 3. For 
HSD17B3 the pair-wise R-squared values for three of the four SNPs ranged from 0.72 to 
0.99; values for the fourth SNP (rs2026001) were all 0.06. For SRD5A2, R-squared values 
ranged from 0.54–0.95, with the exception of rs725631 and rs765138 (range 0.01–0.17). 
The R-squared for the two STARD3 SNPs was low (0.03). For STS SNPs, the range was 
0.54–0.98.
Haplotype analyses among the overall study population gave even stronger results. In 
particular, for HSD17B3, 14-SNP and 5-SNP blocks had odds ratios of 1.5 (95% CI 1.1, 2.0, 
p<0.001) and 2.8 (95% CI 1.6, 4.8, p<0.001), respectively (Table 4). For SRD5A2, 9-SNP, 
3-SNP and 8-SNP blocks had odds ratios of 1.7 (95% CI 1.3, 2.2, p<0.001), 1.4 (95% CI 
1.1, 1.8, p=0.008) and 1.5 (95% CI 1.2, 1.9, p=0.002), respectively.
Based on the risk scores, a higher number of genes with risk-associated SNPs corresponded 
with higher ORs (Table 5). For example, among moderate cases a score of one or two was 
associated with a 2-fold increased risk, whereas a score of three was associated with a 4.5-
fold increased risk.
DISCUSSION
This study indicates that SNPs in several genes that contribute to sex hormone biosynthesis 
and metabolism are associated with risk of hypospadias – CYP3A4, HSD17B3, HSD3B1, 
SRD5A2, STARD3 and STS. However, the study did not indicate that SNPs in several other 
genes contribute to hypospadias – COMT, CYP11A1, CYP17A1, CYP19A1, CYP1A1, 
CYP21A2, CYP3A7, HSD17B1, HSD17B2, HSD3B2, SRD5A1, STAR, SULT1E1, and 
SULT2A1. Our discussion focuses on our findings for the six genes with significant results 
and the three additional genes that have been studied previously but were not significant in 
our study (CYP1A1, CYP17A1, and HSD3B2).
CYP1A1 contributes to the 2-hydroxylation of estrogens, which yields less estrogenic 
metabolites than the 4- and 16-alpha hydroxylation catalyzed by CYP3A4 (Kurahashi and 
others, 2005). Two previous studies have examined two known functional polymorphisms in 
CYP1A1 (rs4646903 and rs1048943). A study of 31 Japanese cases reported a protective 
association with rs4646903 (Kurahashi and others, 2005), whereas a study of 80 Indian 
cases did not provide evidence for association with rs4646903 or rs1048943 (Shekharyadav 
and others, 2011). Our study included rs1048943, as well as three other CYP1A1 SNPs, but 
found no evidence of association. We did observe an increased risk with one CYP3A4 SNP 
for moderate cases. A study of 98 Japanese cases did not find evidence for an association 
with variants in CYP1A1 or CYP3A4 (Qin and others, 2012).
HSD17B3 is responsible for conversion of androstenedione to testosterone. One study 
examined five SNPs in HSD17B3 among 89 Japanese cases (Sata and others, 2010). The 
SNP rs2066479 (+913G>A) was associated with increased risk, regardless of severity; the 
OR for the GA genotype was 1.5 (95% CI 0.9, 2.4), and for the AA genotype it was 3.1 
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(95% CI 1.4, 6.8). Our study included 56 HSD17B3 SNPs. Three were associated with 
increased hypospadias risk; associations were strongest for the homozygous variant 
genotype and among moderate to severe cases. We did not include rs2066479 in our study, 
but we were able to obtain data on its R-squared value with one of our associated SNPs, 
rs12552648, from dbSNP; the R-squared value was near one. In our study, rs12552648 
variant genotypes were associated with increased risk of moderate and severe hypospadias. 
One of our studied SNPs was associated with reduced hypospadias risk, and two haplotype 
blocks were also associated with increased risk.
HSD3B1 and HSD3B2 are important for synthesis of androgens and progesterone. HSD3B2 
mutations lead to impaired gonadal steroidogenesis and undermasculinized genitalia 
(Codner and others, 2004). HSD3B1 has a similar function as HSD3B2 but is the major form 
expressed in the placenta (Pezzi and others, 2003; Simard and others, 2005). In the current 
study, one of six SNPs in HSD3B1 was associated with hypospadias, particularly among 
moderate cases; none of the five HSD3B2 SNPs was associated. A study in Chile observed 
missense mutations in HSD3B2 in two of 90 isolated moderate/severe hypospadias cases, 
versus none among 100 “healthy fertile male controls” (Codner and others, 2004).
SRD5A2 is critical to the conversion of testosterone to DHT in the urethral seam. The V89L 
polymorphism (rs523349 or +336G>C) has been associated with hypospadias in four small 
studies (Samtani and others, 2011; Sata and others, 2010; Thai and others, 2005; Wang and 
others, 2004) but not one large study (van der Zanden and others, 2010). The C allele 
confers substantial reduction in enzyme activity (Samtani and others, 2010). In our study, 
several SRD5A2 SNPs were associated with hypospadias risk, but rs523349 did not make 
the p<0.01 cut-off. Among all cases, the OR for rs523349 was 1.1 (95% CI 0.8, 1.3) for the 
CG genotype and 0.8 (95% CI 0.6, 1.1) for the CC genotype, relative to GG. For mild cases, 
the respective ORs were 1.3 and 1.3, and for moderate cases, 1.0 and 1.0. For severe cases, 
the respective ORs were 1.0 (95% CI 0.7, 1.4) and 0.5 (95% CI 0.3, 0.9, p=0.012). 
Explanation of the differences across studies for this SNP is unknown. ORs for the SRD5A2 
SNPs that did make our p<0.01 cut-off tended to be strongest for the homozygous variant 
genotypes.
The first and rate-limiting step in sex steroid biosynthesis is the conversion of cholesterol to 
pregnenolone, which involves STARD3 (Tuckey and others, 2004). We observed an 
association of two of six STARD3 SNPs with hypospadias, one with a 3-fold increased risk 
of severe hypospadias, and one with reduced risk of moderate and severe hypospadias; both 
results were only observed among Hispanics. STS contributes to the synthesis of 
biologically active estrogens. Seven of 20 SNPs we studied were associated with modestly 
(1.4-fold) increased risk of hypospadias. We are unaware of previous studies of hypospadias 
and genetic variation of STARD3 or STS. CYP19A1 catalyzes the last steps of estrogen 
synthesis. Its SNPs were not associated with hypospadias in our study, nor in another small 
study (Qin and others, 2012).
CYP17A1 (p450c17) is key to synthesis of androgens, estrogens and progestins (Miller, 
2002). Case reports suggest that mutations in CYP17 or reduced CYP17 activity may be 
associated with hypospadias and male pseudohermaphroditism (Ammini and others, 1997; 
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Sherbet and others, 2003). Two small studies among Indian subjects examined the 
functional CYP17A1 polymorphism rs743572; one reported increased risk (Samtani and 
others, 2010), whereas the other did not (Yadav and others, 2011). A small study of 
Japanese subjects reported an association of rs17115149 with hypospadias (Qin and others, 
2012; Samtani and others, 2010). Our study did not provide evidence of an association of 
hypospadias with nine CYP17A1 SNPs, including rs743572; we did not include rs17115149 
in our study.
In summary, of the six genes with results that we considered significant (see Table 3), two 
contribute to estrogen metabolism or synthesis (CYP3A4, STS), three contribute to androgen 
synthesis (HSD17B3, HSD3B1, SRD5A2), and one is more generally involved in steroid 
synthesis (STARD3). Thus, they represent multiple aspects of sex hormone synthesis and 
metabolism. However, we do not know the actual functional consequences of the studied 
SNPs, since most tagSNPs are intronic.
The strengths of this study include its size, population-based controls, ancestry informative 
markers, and examination of multiple genes that contribute to a specific pathway. Many of 
the genes we examined have not been studied previously for their contribution to 
hypospadias, or if they have, previous studies tend to be small in number of subjects and 
variants investigated. Our approach of highlighting results with p<0.01 rather than a more 
conservative statistical criterion minimizes Type II errors (false negatives), but the trade-off 
is an increased possibility of false positive results (Type I error). Given that we had an a 
priori hypothesis about the studied genes, and most have not been studied extensively if at 
all in the context of hypospadias, this seemed an appropriate trade-off for the presentation of 
results. However, some of our results may be false positives, since the p-value criterion of 
<0.01 was not very conservative relative to the large number of comparisons we made. 
Thus, we emphasize the need for replication of our findings in additional study populations. 
Under-ascertainment of mild cases is a potential limitation of this study but would not alter 
the associations we observed for moderate or severe hypospadias. We considered all cases in 
our study regardless of whether they had other accompanying congenital malformations; 
most cases did not have other malformations and thus those with other malformations are 
unlikely to have driven our results. Our approach of investigating tagSNPs was justified 
given that it captures the majority of genetic variation and is cost-efficient, and that minimal 
examination of the studied genes in humans preceded the current study. However, many 
tagSNPs are intronic and have no known functional consequences. The SNPs we genotyped 
include one non-synonymous exonic SNP (STARD3 rs1877031) and two 3′-UTR 
(untranslated region) SNPs (SRD5A2 rs1042578 and rs9332975). Thus, some of the 
observed associations could be driven by linkage disequilibrium with other less common, 
unmeasured variants that do have functional (but still uncertain) consequences. In addition, 
several of the associations we have reported were for SNPs that were in relatively high 
disequilibrium and are therefore unlikely to be independent. Our study investigated 
confounding by race-ethnicity as well as effect modification for Hispanics versus non-
Hispanic whites. A limitation of our study is the small numbers of subjects with other race-
ethnicities, such as Asian or Pacific Islander.
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In conclusion, this study observed substantial evidence for an association of hypospadias 
with certain genes that contribute to sex hormone biosynthesis and metabolism, especially 
HSD17B3, SRD5A2, and STS. Further studies are needed to verify these results and identify 
potential underlying causal variants.
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Candidate genes from the sex steroid biosynthesis pathway.
DHEA = Dehydroepiandrosterone, DHEAS = DHEA-sulfate, see Table 1 for gene names
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Table 1
Genes included in analyses.




COMT catechol-O-methyltransferase Inactivates estrogens 19
CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide 
1
Conversion of cholesterol to pregnenolone 5
CYP17A1 cytochrome P450, family 17, subfamily A, polypeptide 
1
Conversion of pregnenolone and progesterone 9
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 
1
Conversion of androgens to estrogens 64
CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1 Contributes to the 2-hydroxylation of estrogens 4
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 Contributes 4- and 16a-hydroxylation of 
estrogens
9
CYP3A7 cytochrome P450, family 3, subfamily A, polypeptide 7 Contributes to fetal supply of androgen 
precursors of estrogens by generating 16OH-
DHEAS, the major precursor for placental 
estriol synthesis
3
HSD17B1 hydroxysteroid (17-beta) dehydrogenase 1 Inter-conversion of estrogens and androgens, 
e.g., conversion of estrone to estradiol
1
HSD17B2 hydroxysteroid (17-beta) dehydrogenase 2 Inter-conversion of estrogens and androgens; 
e.g., conversion of estradiol to estrone
51
HSD17B3 hydroxysteroid (17-beta) dehydrogenase 3 Inter-conversion of estrogens and androgens 56
HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and 
steroid delta-isomerase 1
Interconversion of androgens and progesterone-
related hormones
6
HSD3B2 hydroxy-delta-5-ster0oid dehydrogenase, 3 beta- and 
steroid delta-isomerase 2
Interconversion of androgens and progesterone-
related hormones
5
SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 Isoform of SRD5A2 22
SRD5A2 steroid-5-alpha-reductase, alpha polypeptide 2 Conversion of testosterone to 
dihydrotestosterone
31
STAR steroidogenic acute regulatory protein Conversion of cholesterol to pregnenolone 1
STARD3 StAR-related lipid transfer (START) domain containing 
3
Conversion of cholesterol to pregnenolone 6
STS steroid sulfatase (microsomal), isozyme S Contributes to placental generation of estriol by 
catalyzing conversion of sulfated steroid 
precursors to estrogens
20
SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 
1
Inactivates estrogens by sulfoconjugation 13
SULT2A1 sulfotransferase family, cytosolic, 2A, DHEA-
preferring, member 1
Conversion of DHEA to DHEAS 7
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Table 2
Descriptive characteristics of cases with hypospadias (n=633) and non-malformed controls (n=855).
Percent of Controls (n) Percent of Cases (n)
Maternal race-ethnicity
 White 31 (262) 43 (275)
 Hispanic 52 (443) 35 (221)
 Others 18 (150) 22 (137)
Maternal education
 < High school 39 (335) 26 (162)
 High school 31 (264) 27 (173)
 > High school 29 (249) 47 (296)
 Unknown 1 (7) <1 (2)
Maternal age
 < 25 years 46 (395) 30 (189)
 25–34 years 43 (365) 52 (331)
 35 or more years 11 (95) 18 (113)
Number of previous live births
 0 36 (309) 52 (331)
 1 32 (276) 26 (163)
 ≥ 2 32 (270) 22 (137)
 Unknown 0 (0) <1 (2)
Infant birthweight
 ≤ 2500 g 5 (42) 30 (192)
 > 2500 g 95 (813) 70 (441)
Gestational age at delivery
 < 37 weeks 7 (60) 23 (143)
 ≥ 37 weeks 89 (758) 74 (468)
 Unknown 4 (37) 3 (22)
Maternal residence in Central Valley
 No 45 (385) 63 (394)
 Yes 55 (470) 37 (239)
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